Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 205,667 | 241,198 | -56,569 | 28,507 | 79,203 |
| Depreciation Amortization | 3,028 | 2,062 | 1,046 | 5,276 | 4,243 |
| Accounts receivable | 101,895 | 106,161 | 50,891 | 149,350 | 93,024 |
| Accounts payable and accrued liabilities | -14,468 | 833 | 13,042 | -3,938 | -10,280 |
| Other Working Capital | -22,182 | -12,793 | 10,859 | 57,288 | 1,356 |
| Other Operating Activity | -392,737 | -409,919 | -45,095 | -256,923 | -216,594 |
| Operating Cash Flow | $-118,797 | $-72,458 | $-25,826 | $-20,440 | $-49,048 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -89,576 | -20,726 | N/A | N/A | 0 |
| Sale Of Investment | 1,650 | 0 | 0 | 14,888 | 14,888 |
| Other Investing Activity | 465,851 | 465,878 | -17,486 | 215,433 | 215,975 |
| Investing Cash Flow | $377,925 | $445,152 | $-17,486 | $230,321 | $230,863 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 36,979 | 36,979 |
| Debt Repayment | -233,185 | -233,185 | N/A | -260,387 | -260,387 |
| Common Stock Issued | N/A | N/A | N/A | 1,746 | 1,455 |
| Common Stock Repurchased | 188 | 188 | N/A | 926 | 685 |
| Other Financing Activity | -48,789 | -48,791 | -264 | 33,762 | 34,063 |
| Financing Cash Flow | $-281,786 | $-281,788 | $-264 | $-186,974 | $-187,205 |
| Beginning Cash Position | 126,250 | 126,250 | 126,250 | 103,343 | 103,343 |
| End Cash Position | 103,592 | 217,156 | 82,674 | 126,250 | 97,953 |
| Net Cash Flow | $-22,658 | $90,906 | $-43,576 | $22,907 | $-5,390 |
| Free Cash Flow | |||||
| Operating Cash Flow | -118,797 | -72,458 | -25,826 | -20,440 | -49,048 |
| Free Cash Flow | -118,797 | -72,458 | -25,826 | -20,440 | -49,048 |